Tamarack Advisers, LP Ascendis Pharma A/S Transaction History

Tamarack Advisers, LP

  • $2.12 Billion
  • Q4 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023
SELL
$104.9 - $126.78 $2.62 Million - $3.17 Million
-25,000 Reduced 55.56%
20,000 $2.14 Million
Q4 2022

Feb 10, 2023
BUY
$99.42 - $131.97 $2.98 Million - $3.96 Million
30,000 Added 200.0%
45,000 $5.5 Million
Q2 2022

Aug 16, 2022
BUY
$78.08 - $117.61 $1.17 Million - $1.76 Million
15,000 New
15,000 $1.39 Million

Others Institutions Holding ASND

# of Institutions
244
Shares Held
58.8M
Call Options Held
250K
Put Options Held
377K
View Full List

About Ascendis Pharma A/S

ASND Quotes by TradingView
  • Ticker ASND
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,810,200
  • Market Cap $7.61B
  • Description
  • Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...
More about ASND
Track This Portfolio

Track Tamarack Advisers, LP Portfolio

Follow Tamarack Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tamarack Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Tamarack Advisers, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email